Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post

Fundamental Analysis of Dr Reddys Laboratories Ltd

About the Company - Dr Reddys Laboratories Ltd

Dr. Reddy's Laboratories Ltd. is a Public Limited Listed company incorporated on 24/02/1984 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L85195TG1984PLC004507 and registration number is 004507. Currently Company is involved in the business activities of Manufacture of other pharmaceutical and botanical products like hina powder etc.. Company’s Total Operating Revenue is Rs. 14405.20 Cr. and Equity Capital is Rs. 83.20 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Pharmaceuticals8-2-337, Road No. 3, Hyderabad Telangana 500034shares@drreddys.com
http://www.drreddys.com
Management
NamePosition Held
Mr. K Satish ReddyChairman
Mr. G V PrasadCo-Chairman & Manag. Director
Ms. Kalpana MorpariaIndependent Director
Mr. Leo PuriIndependent Director
Dr. Claudio AlbrechtIndependent Director
Ms. Shikha SharmaIndependent Director
Ms. Penny WanIndependent Director
Mr. Sridar IyengarIndependent Director
Mr. Arun Madhavan KumarIndependent Director
Dr. K P KrishnanIndependent Director

Dr. Reddy's Laboratories Ltd. Share Price Update

Share PriceValue
Today₹5,719.85
Previous Day₹5,671.25

Basic Stock Data of Dr Reddys Laboratories Ltd

Dr Reddys Laboratories Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales4,9114,9424,7684,9455,7875,3385,4755,2336,3326,7906,3156,7586,903
Expenses3,7554,4033,7154,2114,4274,1235,0244,2924,4334,8514,7814,6964,894
Operating Profit1,1565391,0537341,3601,2164519411,8991,9391,5342,0622,008
OPM %24%11%22%15%24%23%8%18%30%29%24%31%29%
Other Income5886100124230741328635565146178319
Interest25193019232232353142353735
Depreciation316311309284294294293302309324316353376
Profit before tax8732958155561,2729742591,4681,6141,6381,3291,8501,917
Tax %12%91%32%32%22%27%63%19%31%24%28%24%23%
Net Profit77228557380996709971,1891,1141,2449601,4051,482
EPS in Rs46.421.6833.5122.8759.8442.625.8371.4466.9374.7057.6584.3688.87

Dr Reddys Laboratories Ltd Quarterly Chart

Dr Reddys Laboratories Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales9,81411,83313,41515,02315,56814,19614,28115,44817,51719,04821,54524,67026,766
Expenses7,3719,16410,16411,51511,98311,72411,93012,27015,04015,17317,77818,20019,223
Operating Profit2,4442,6693,2513,5083,5852,4722,3513,1782,4773,8743,7686,4707,543
OPM %25%23%24%23%23%17%16%21%14%20%17%26%28%
Other Income-7146170260295172155381670335555971708
Interest11410012710883637989989796143150
Depreciation5185506487609391,0271,0771,1351,1631,2291,1651,2501,368
Profit before tax1,8042,1652,6462,9002,8591,5541,3502,3361,8862,8843,0616,0486,734
Tax %28%29%26%19%26%19%32%17%-7%32%29%25%
Net Profit1,3011,5271,9632,3362,1311,2929471,9502,0261,9522,1824,5075,091
EPS in Rs76.7289.90115.41137.13124.8877.9657.07117.42121.92117.35131.14270.66305.58
Dividend Payout %18%17%16%15%16%26%35%17%21%21%23%15%

Dr Reddys Laboratories Ltd Profit & Loss Yearly Chart

Dr Reddys Laboratories Ltd Growth

Compounded Sales Growth
10 Years::8%
5 Years::12%
3 Years::12%
TTM::20%

Dr Reddys Laboratories Ltd Growth

Compounded Profit Growth
10 Years::12%
5 Years::39%
3 Years::31%
TTM::64%

Dr Reddys Laboratories Ltd Growth

Stock Price CAGR
10 Years::9%
5 Years::16%
3 Years::6%
1 Year::28%

Dr Reddys Laboratories Ltd Growth

Return on Equity
10 Years::15%
5 Years::15%
3 Years::15%
Last Year::22%

Dr Reddys Laboratories Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital85858585858383838383838383
Reserves4,9046,2847,7809,76812,48412,17912,48913,94115,51617,55819,12923,20325,413
Borrowings3,2343,6824,4774,3143,3524,9185,0713,8382,2103,0313,3841,3471,323
Other Liabilities3,0823,3293,5634,2904,4084,4744,7064,5575,4145,9157,1497,5767,990
Total Liabilities11,30513,38015,90618,45720,33021,65422,34922,41823,22326,58829,74632,20934,809
Fixed Assets3,4124,0514,6415,3776,5636,9316,9687,1916,8508,2068,1229,21910,090
CWIP7085656395297723,3243,4702,9341,5351,5651,2931,0301,151
Investments2081971,0672,2483,8332,1102,2982,5872,6782,2122,6164,9864,457
Other Assets6,9778,5679,55910,3039,1629,2909,6129,70712,16014,60517,71516,97419,111
Total Assets11,30513,38015,90618,45720,33021,65422,34922,41823,22326,58829,74632,20934,809

Dr Reddys Laboratories Ltd Reserves and Borrowings Chart

Dr Reddys Laboratories Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 1,6131,3781,9702,5243,2632,1441,8032,8702,9843,5702,8115,888
Cash from Investing Activity -971-1,437-1,604-2,370-1,610-1,890-1,483-769-495-2,255-2,565-4,109
Cash from Financing Activity 389-157-24-433-1,700-369-444-2,133-2,516-30-242-2,686
Net Cash Flow1,031-216342-280-47-114-124-31-271,2863-907

Dr Reddys Laboratories Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days94989010097981049410595113107
Inventory Days282229271248248282263273230273250232
Days Payable1101021008488104121111100109111108
Cash Conversion Cycle267225261264257275246256235259252231
Working Capital Days8179887987981049393103108102
ROCE %28%25%25%22%19%9%8%13%11%16%14%27%

Dr Reddys Laboratories Ltd Financial Efficiency Indicators Chart

No valid data available for the Shareholding

Dr Reddys Laboratories Ltd Shareholding Pattern Chart

No. of Dr Reddys Laboratories Ltd Shareholders

Dr Reddys Laboratories Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
SBI Nifty 50 ETF22596100.781212.86
HDFC Flexi Cap Fund - Regular Plan12000001.63644.11
Parag Parikh Flexi Cap Fund8118350.99435.76
HDFC ELSS Tax Saver Fund6000002.86322.05
Nippon India Pharma Fund5500305.33295.23
SBI Arbitrage Opportunities Fund3277500.79175.92
HDFC Arbitrage Fund - Regular Plan3042502.16163.31
HDFC Arbitrage Fund - Wholesale Plan3042502.16163.31
Mirae Asset Healthcare Fund2823468.5151.55
Tata Equity P/E Fund - Regular Plan2700002.43144.92

Dr Reddys Laboratories Ltd ROCE Trend

Dr Reddys Laboratories Ltd EPS Trend

Dr Reddys Laboratories Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue5.005.005.005.005.00
Basic EPS (Rs.)271.47131.57117.67122.22117.53
Diluted EPS (Rs.)270.90131.21117.34121.99117.33
Cash EPS (Rs.)343.37196.96188.25188.51183.19
Book Value[Excl.RevalReserv]/Share (Rs.)1397.721154.591060.20938.56844.79
Book Value[Incl.RevalReserv]/Share (Rs.)1397.721154.591060.20938.56844.79
Revenue From Operations / Share (Rs.)1480.771294.781144.681053.97930.61
PBDIT / Share (Rs.)444.45255.53250.08185.98211.79
PBIT / Share (Rs.)369.41185.51176.23116.00143.43
PBT / Share (Rs.)360.83179.75170.40110.08138.07
Net Profit / Share (Rs.)268.32126.94114.40118.53114.83
NP After MI And SOA / Share (Rs.)270.55131.16117.28121.90117.47
PBDIT Margin (%)30.0119.7321.8417.6422.75
PBIT Margin (%)24.9414.3215.3911.0015.41
PBT Margin (%)24.3613.8814.8810.4414.83
Net Profit Margin (%)18.129.809.9911.2412.33
NP After MI And SOA Margin (%)18.2710.1210.2411.5612.62
Return on Networth / Equity (%)19.3511.3511.0612.9813.90
Return on Capital Employeed (%)25.9515.4415.8412.0414.37
Return On Assets (%)13.967.337.338.728.67
Long Term Debt / Equity (X)0.000.010.020.010.15
Total Debt / Equity (X)0.040.160.150.110.24
Asset Turnover Ratio (%)0.610.560.590.560.54
Current Ratio (X)2.381.821.801.751.88
Quick Ratio (X)1.811.301.241.261.31
Inventory Turnover Ratio (X)0.770.851.030.920.85
Dividend Payout Ratio (NP) (%)11.0418.9921.2419.3217.02
Dividend Payout Ratio (CP) (%)8.6412.3813.0312.2710.76
Earning Retention Ratio (%)88.9681.0178.7680.6882.98
Cash Earning Retention Ratio (%)91.3687.6286.9787.7389.24
Interest Coverage Ratio (%)51.8544.3942.9031.4439.55
Interest Coverage Ratio (Post Tax) (%)32.3023.0520.6221.0422.44
Enterprise Value (Cr.)76382.9972310.8675755.2853384.5049240.59
EV / Net Operating Revenue (X)3.103.363.983.053.19
EV / EBITDA (X)10.3217.0118.2017.2714.01
MarketCap / Net Operating Revenue (X)3.123.333.942.962.98
Retention Ratios (%)88.9581.0078.7580.6782.97
Price / BV (X)3.313.734.263.323.28
Price / Net Operating Revenue (X)3.123.333.942.962.98
EarningsYield0.050.030.020.030.04

Dr Reddys Laboratories Ltd Profitability Ratios (%)

Dr Reddys Laboratories Ltd Liquidity Ratios

Dr Reddys Laboratories Ltd Liquidity Ratios (%)

Dr Reddys Laboratories Ltd Interest Coverage Ratios (%)

Dr Reddys Laboratories Ltd Valuation Ratios

Data is incomplete for fair value calculation.

Strength and Weakness of Dr Reddys Laboratories Ltd Stock

StrengthWeakness

The company has higher reserves compared to borrowings, indicating strong financial stability.

The company has shown consistent growth in sales and profit over the years.

The stock has a low average ROCE, which may not be favorable.

The stock has a high average Working Capital Days, which may not be favorable.

The stock has a high average Cash Conversion Cycle, which may not be favorable.

Related Posts